Endogenous selective inhibitors of 11β-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin

Molecular and Cellular Endocrinology

Volumn 243, Issue 1-2, 2005, Pages 43-50

  Latif, Syed A ^a   Pardo, Hector A ^a   Hardy, Matthew P ^b   Morris, David J ^a  

^a BROWN UNIVERSITY   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

11 HSD1; 11 HSD2; Adrenal steroids; Inhibitors; Metabolites

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE DERIVATIVE; ELTANOLONE; OXIDOREDUCTASE INHIBITOR; PROGESTERONE DERIVATIVE; TESTOSTERONE DERIVATIVE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADRENAL GLANDS; ANIMALS; ISOENZYMES; LEYDIG CELLS; MALE; MICROSOMES; RATS; SHEEP; STEROIDS;

EID: 27644453205     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.08.006     Document Type: Article

References (39)

1. P. Alberts, L. Engblom, N. Edling, M. Forsgren, G. Klingstrom, C. Larrson, Y. Ronquist-Nii, B. Ohman, and L. Abrahmsen Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice Diabetologia 45 2002 1528 1532
2. S. Andersson, and N. Moghrabi Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenase Steroids 62 1997 143 147
3. V.D. Bokkenheuser, J. Winter, J.W. Honour, and C.H.L. Shackleton Reduction of aldosterone by anaerobic bacteria: origin of 21-deoxy metabolites in man J. Steroid Biochem. 11 1979 1145 1149
4. A.S. Brem, R.B. Bina, T. King, and D.J. Morris 11β-OH-progesterone affects vascular glucocorticoid metabolism and contractile response Hypertension 30 I 1997 449 454
5. I.J. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart A switch in dehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells J. Clin. Endocrinol. Metab. 87 2002 1205 1210
6. I.E. Bush, S.A. Hunter, and R.A. Meigs Metabolism of 11-oxygenated steroids Biochem. J. 107 1968 239 257
7. T.E. Chapman, G.P. Kraan, G.T. Nagel, B.G. Wolthers, and N.M. Drayer Measurement of the cortisol production rate in two sisters with 17α-hydroxylase deficiency using [1,2,3,4-13C] cortisol and isotope dilution mass spectrometry J. Steroid Biochem. Mol. Biol. 38 1991 489 496
8. C.L. Cope Metabolic breakdown C.L. Cope Adrenal Steroids and Disease 1972 Pitman Medical London 80 104
9. S. Diederich, C. Grossmann, B. Hanke, M. Quinkler, M. Herrmann, V. Bahr, and W. Oelkers Eur. J. Endocrinol. 142 2000 200 207
10. F.M. Ganis, L.R. Axlerod, and L.L. Miller The metabolism of hydrocortisone by kidney tissue in vitro J. Biol. Chem. 218 1956 814 820
11. H.B. Gao, R.S. Ge, V. Lakshmi, A. Marandici, and M.P. Hardy Hormonal regulation of oxidative and reductive activities of 11β-hydroxysteroid dehydrogenase in rat Leydig cells Endocrinology 138 1997 156 161
12. J. Gorsline, S.A. Latif, and D.J. Morris Changes in 5α- and 5β-reductase pathways of aldosterone metabolism by dietary sodium Am. J. Hypertens. 1 1988 272 275
13. J. Honour The possible involvement of intestinal bacteria in steroidal hypertension Endocrinology 110 1982 285 287
14. N. Khan, K.K. Sharma, S. Andersson, and R.J. Auchus Human 17β-hydroxysteroid dehydrogenase types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism Arch. Biochem. Biophys. 429 2004 50 59
15. L. Kornel, W.R. Starnes, S.R. Holl Jr., and A. Hill Studies on steroid conjugates. Part VI: quantitative paper chromatography of urinary corticosteroids in essential hypertension J. Clin. Endocrinol. Metab. 29 1969 1608 1617
16. L. Kornel Co-localization of 11β-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells Am. J. Hypertens. 7 1994 100 103
17. A. Kumagai, S. Yano, M. Otomo, and K. Takeuchi Study on the corticoid-like action of glycyrrhizine and the mechanism of action Endocrinol. Jpn. 4 1957 17 27
18. S.A. Latif, T.J. Conca, and D.J. Morris The effects of the liquorice derivatives, glycyrrhetinic acid on hepatic 3α- and 3β-hydroxy dehydrogenases and 5α- and 5β-reductase pathways of metabolism of aldosterone in male rats Steroids 55 1990 52 58
19. S.A. Latif, M.F. Sheff, C.E. Ribeiro, and D.J. Morris Selective inhibition of sheep kidney 11β-hydroxysteroid dehydrogenase isoform 2 activity by 5α-reduced (but not 5β) derivatives of adrenocorticosteroids Steroids 62 1997 230 237
20. C. Monder, and P.C. White 11β-Hydroxysteroid dehydrogenase Vitamins Hormones 47 1993 187 269
21. + retention and hypertension Endocr. Res. 22 1996 793 801
22. D.J. Morris, A.S. Brem, R. Ge, H.P. Jellinck, R.R. Sakai, and M.P. Hardy The functional roles of 11β-HSD1: vascular tissue, testis and brain Mol. Cell. Endocrinol. 203 2003 1 12
23. + on glycyrrhetinic acid-like factors (kidney-11B-HSD2 GALFs) in human essential hypertension Hypertension 31 1998 469 472
24. D.J. Morris, W.E. Semafuko, S.A. Latif, B. Vogel, C.A. Grimes, and M.F. Sheff Detection of glycyrrhetinic acid-like factors (GALFs) in human urine Hypertension 20 1992 356 360
25. B.E. Pearson Murphy Demonstration of novel compounds inhuman fetal tissues and a consideration of their possible role in parturition Am. J. Obstet. Gynecol. 139 1981 353 358
26. G. Pelletier, V. Luu-The, S. Li, and F. Labrie Localization of type 7 17β-hydroxysteroid dehydrogenase in mouse tissues: in situ hybridization studies J. Steroid Biochem. Mol. Biol. 93 2005 49 57
27. S. Rauz, C.M.G. Cheung, P.J. Wood, M. Coca-Prados, E.A. Walker, P.I. Murray, and P.M. Stewart Inhibition of 11β-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension Q. J. Med. 96 2003 481 490
28. E. Rusvai, and A. Naray-Fejes-Toth A new isoform of 11β- hydroxysteroid dehydrogenase in aldosterone target cells J. Biol. Chem. 268 1993 10717 10720
29. J.R. Seckl, and B.R. Walker 11β-Hydroxysteroid dehydrogenase type 1-A tissue-specific amplifier of glucocorticoid action Endocrinology 142 2001 1371 1376
30. A. Soro, M.C. Ingram, G. Tonolo, N. Glorioso, and R. Fraser Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in subjects with untreated essential hypertension Hypertension 25 1 1995 67 70
31. C.H.L. Shackleton, E.G. Biglieri, E. Roitman, and J.W. Honour Metabolism of radiolabeled coticosterone in an adult with the 17α-hydroxylase deficiency syndrome J. Clin. Endocrinol. Metab. 48 1979 976 982
32. G.W. Souness, A.S. Brem, and D.J. Morris 11β-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism Steroids 67 2002 195 201
33. P.M. Stewart, A.M. Wallace, R. Valentino, D. Burt, Shackleton C.H.L., and C.R.W. Edwards Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age Lancet 2 1987 821 824
34. J.W. Tomlinson, E.A. Walker, I.J. Bujalska, N. Draper, G.G. Lavery, M.S. Cooper, M. Hewison, and P.M. Stewart 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response Endocr. Rev. 25 2005 831 866
35. S. Ulick, L.S. Levine, P. Gunczler, G. Zanconato, L.C. Ramirez, W. Rauh, A. Rosler, and H.L. Bradlow A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol J. Clin. Endocrinol. Metab. 49 1979 757 764
36. B.R. Walker, P.M. Stewart, C. Shackleton, P.L. Padfield, and CR.W. Edwards Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension Clin. Endocrinol. 39 1993 221 227
37. G.-M. Wang, R.-S. Ge, S.A. Latif, D.J. Morris, and M.P. Hardy Leydig cells express 11β-hydroxylase message and 11β-hydroxlated androgens inhibit 11β-HSD1 enzymatic activity Endocrinology 143 2002 621 626
38. P.C. White, T. Mune, and A.K. Agarwal 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess Endocr. Rev. 18 1997 135 156
39. R.C. Wilson, M.D. Harbison, Z.S. Krozowski, J.W. Funder, C.H. Shackleton, H.M. Hanauske-Abel, J.Q. Wei, J. Hertecant, A. Moran, and R.E. Neiberger Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess J. Clin. Endocrinol. Metab. 80 1995 3145 3150